Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
Journal Title: Cardiology Journal - Year 2009, Vol 16, Issue 2
Abstract
Dual antiplatelet therapy is currently recommended for all patients with acute coronary syndromes, independent of whether they receive pharmacological treatment or undergo percutaneous coronary intervention. Antiplatelet agents are the cornerstone of pharmacological treatment in interventional cardiology. However, there is a clear need for randomized trials to assess the treatment strategy of dual antiplatelet therapy in patients who also need long-term antithrombotic treatment (such as those with atrial fibrillation, prosthetic heart valve, mitral valve regurgitation or stenosis, deep vein thrombosis, pulmonary embolism, or pulmonary hypertension). In this paper we discuss trials and analyses on the use of dual antiplatelet treatment in combination with antithrombotic therapy in particular diseases, with a focus on the risk of hemorrhagic events connected with this treatment, as well as recent guidelines of the European Society of Cardiology, the American College of Cardiology, and the American Heart Association.
Authors and Affiliations
Leszek Bryniarski, Agnieszka Pelc-Nowicka, Michał Zabojszcz, Ewa Mirek-Bryniarska
Keywords
Related Articles
- EP ID EP85105
- DOI -
- Views 76
- Downloads 0
Karel Frederick Wenckebach (1864-1940): A giant of medicine.
Congenital left main coronary artery aneurysm.
Left main coronary artery aneurysm (LMCAA) is an uncommon coronary abnormality seen in 0.1% of patients during routine diagnostic coronary angiographies. The most common etiology is atherosclerosis in acquired cases. How...
Congenital heart disease, exercise capacity and B-type natriuretic peptide.
Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
Adult patients with congenital heart disease (CHD) usually find their exercise capacity satisfactory. However, objective evaluation is important for diagnostic and prognostic purposes. The aim of this study was to evalua...
Committed function for the first delivered shock of an uncommitted implantable cardioverter-defibrillator.